Hubble Therapeutics, LLC
Hanover, US · Founded 2020 · Delaware LLC · 1 known investors
Founders & leadership
JS
Jeff SabadosExecutive
Board
SG
GK
Greg KeenanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$9.8M disclosed across 1 round · 2024
▶$9.8MraisedOct 2024 · 17 investors · BiotechnologyRule 506(b)
▶$9.8MraisedOct 2024 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff SabadosExecutive Officer, Director
- Sam GoldbergerDirector
- Greg KeenanDirector
- Offering amount
- $11.1M
- Amount sold
- $9.8M
- First sale
- Oct 2024
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Hubble Therapeutics, LLC's investors?
- Hubble Therapeutics, LLC's investors include Ambit Health Ventures.
- How much funding has Hubble Therapeutics, LLC raised?
- Hubble Therapeutics, LLC has disclosed $9.8M raised across 1 round.
- Where is Hubble Therapeutics, LLC headquartered?
- Hubble Therapeutics, LLC is headquartered in Hanover, US.